Fmr LLC Cytokinetics Inc Transaction History
Fmr LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Fmr LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Fmr LLC holds 10,316,131 shares of CYTK stock, worth $330 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,316,131
Previous 10,794,686
4.43%
Holding current value
$330 Million
Previous $508 Million
18.35%
% of portfolio
0.03%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$470 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$379 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$319 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$256 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$195 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.01B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...